Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fudosteine in stable neutrophilic COPD
ChiCTR2000039900Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fudosteine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Blood routine examination, Pulmonary function and 5 more. Started Jan 2021; status: recruiting.
02
Drugs
fudosteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2000039900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039900.